AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Science Magazine Podcast
Trialing treatments for Long Covid, and a new organelle appears on the scene
Apr 11, 2024
Clinicians and researchers discuss trials for Long Covid treatments, including HIV drugs and monoclonal antibodies. A symbiosis expert introduces the new organelle called nitroplast. They explore the benefits of having nitrogen-fixing organelles in cells and the challenges of studying and treating Long Covid
33:09
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Researchers are actively testing drugs and antibodies against long COVID to address the root causes of the syndrome.
- Researchers are exploring theories like viral persistence and immune dysfunction to find effective treatments for long COVID.
Deep dives
Long COVID Trials and Treatments
Researchers are actively testing drugs and antibodies against long COVID, aiming to address the root causes of the syndrome rather than just its symptoms. With a lack of proven treatments currently available, individuals like Shelley Hayden have turned to self-experimentation with supplements and off-label medications in the absence of approved options. Trials are investigating various approaches, including viral persistence theories, to find effective treatments for long COVID.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode